North America Active Pharmaceutical Ingredients Market Analysis and Forecasts to 2020

Report Overview

Table of Contents

949.18

Select License Type

£949.19	Electronic License Electronic License An electronic version (mostly PDF, but can be Excel or PPT), which is either available for immediate download or will be sent via email by the Publisher of the report. The licencing for an electronic version is for use by the purchaser ONLY.
£1,898.37	Site License Site License An electronic version (mostly PDF, but can be Excel or PPT). Where the report(s) is intended for use by more than one individual, across for example, a site, an office, or a division or country.
£2,847.56	Corporate License Corporate License An electronic version (mostly PDF, but can be Excel or PPT). Where the report(s) is/are intended for use by an organisation in its entirety. For example, if reports are put on an Intranet or if they are distributed or used by more than one office, division, or country operation, then a Corporate Licence is required.

£949.19	Add to Wishlist
Change Currency	GBP EURO USD

Market	Chemicals
Report Type	Market Research
Country	United States
Published	5 August 2009
Number of Pages	85
Report Delivery	Email
Delivery Lead Time	-
Publisher	Global Markets Direct

In-depth analysis of the North American active pharmaceutical ingredients (API) market

This new report "North American Active Pharmaceutical Ingredients Market Analysis and Forecasts to 2020" provides in-depth analysis of the North American active pharmaceutical ingredients (API) market and presents revenue forecasts up to 2020 for the United States and Canada. The report is based around the two major product types, namely, synthetic API and biotech API. Revenue forecasts are provided for both the product types. The synthetic API market is further analyzed based on the customer base – generic and innovative sectors. This study also provides detailed insights into the factors affecting the dynamics of the market with strategic analysis of the major trends. Market share analysis of the major companies in the whole North American market is also covered in the report.

Economic Crisis Slows the Revenue Growth of the North American API Market

The current global economic crisis has negatively affected the North American API market leading to a drastic reduction in its growth. The economic crisis has necessitated the need for the governments to reduce their expenditure even in the healthcare sector. Therefore, in an attempt to realize significant savings of the healthcare expenditure, there is a shift away from the high-priced innovative drugs in the United States and Canada. This has resulted in a significant slowdown in the revenue growth of the North American API market. In 2009, the North American API market is set grow at a rate of around 2%.

Biotech APIs Set to Drive the Overall Growth of the API Market in North America

The biotech API market in North America is geared for a higher growth which is set to drive the overall growth of the API market. The increasing demand for the biological drugs is boosting the demand for the biotech API in the market place. Also, the technological advancement in the pharmaceutical industry is paving way for newer biotechnology drugs. The pharmaceutical industry is also optimistic about the approval of biogeneric drugs which is expected to create further growth in the development of the biotech API market. This will boost the growth of the biotech API market making it to grow at a rate significantly higher than the synthetic API market. The biotech API market is expected to grow at a CAGR of around 13% from 2008 to 2020.
Generic APIs Get a Boost Due to the Cost-Containment Measures in North America

The generic APIs in the North American API market is witnessing increased growth as a result of the slew of cost-containment measures followed by the governments of the United States and Canada. Primarily, the API market in North America has been driven by innovative sector. However, the expensive nature of the drugs, that increases the overall healthcare expenditure of the country, has compelled the Government to implement steps that will step up the growth of the generic sector. The low-priced generic drugs enable a cost reduction of around 30-40% due to which it has gained increased acceptance in the wake of recession. As a result of such aggressive measures to boost the growth of the generic drugs in the North American region, the under-developed generic API market is expected to get a stronger boost in its growth. Generic APIs are expected to grow at a CAGR of around 8% from 2008 to 2020 that is significantly higher than the innovative sector which is set to grow at a modest rate of 2% for the same time period in North America.

Canada Poised to Increase its Revenue Share in the North American API Market

The Canadian API market, which held a revenue share of around 6% in 2008, is bound to increase its share to 7% in 2015. The Canadian API market is characterized by an emerging biotech API product segment which is growing fastest in the North American market. Adding to this, Canada is expected to have a quick recovery from the recession compared to the United States which will keep the country’s API market growing at a higher rate. This higher growth is set to enable the Canadian API market to gain revenue share during the period 2008-2020.

North America Active Pharmaceutical Ingredients Market Analysis and Forecasts to 2020

Summary

This report will provide an analysis of the Active Pharmaceutical Ingredients market in key countries of North America region. The report will provide in-depth analysis of volume and revenue of the Active Pharmaceutical Ingredients market in North America. The pricing trend of the market will also be analyzed in the report. This report also contains detailed market share analysis of top companies operating in all the major regions.

Scope

- Detailed analysis of volumes and revenues of Active Pharmaceutical Ingredients in all the major countries in North America and forecasts till 2020
- Detailed analysis of the end applications of Active Pharmaceutical Ingredients in all the major countries in North America
- Detailed analysis and forecasts of Active Pharmaceutical Ingredients prices in all the major countries in North America
- Thorough analysis of key drivers of growth of the Active Pharmaceutical Ingredients market in all the major countries in North America
- Detailed analysis of the market share of the major Active Pharmaceutical Ingredients producing companies in the major countries in North America

Reasons to buy

- The report acts as a guide to the industry professionals and beginners to gain significant understanding about the Active Pharmaceutical Ingredients market in North America
- To identify the most attractive geographies, markets and sectors to increase business
- Develop custom strategies based on the current and forecasted trends in the volumes and revenues of Active Pharmaceutical Ingredients market
- Benchmark different geographies by the historic and forecasted growth of volumes and revenues of Active Pharmaceutical Ingredients and the drivers, restraints and challenges unique to each of the major countries in North America
- Benchmark your company with the top Active Pharmaceutical Ingredient producers with comprehensive information of the market share of top companies operating in each of the major regions

Speak to an Advisor

Call us on
+44 (0) 203 086 8600

Select License Type

£949.19	Electronic License Electronic License An electronic version (mostly PDF, but can be Excel or PPT), which is either available for immediate download or will be sent via email by the Publisher of the report. The licencing for an electronic version is for use by the purchaser ONLY.
£1,898.37	Site License Site License An electronic version (mostly PDF, but can be Excel or PPT). Where the report(s) is intended for use by more than one individual, across for example, a site, an office, or a division or country.
£2,847.56	Corporate License Corporate License An electronic version (mostly PDF, but can be Excel or PPT). Where the report(s) is/are intended for use by an organisation in its entirety. For example, if reports are put on an Intranet or if they are distributed or used by more than one office, division, or country operation, then a Corporate Licence is required.

£949.19	Add to Wishlist
Change Currency	GBP EURO USD

1 Table Of Contents 2
1.1 List of Tables 6
1.2 List of Figures 7
2 Introduction 9
2.1 What is this Report About? 9
2.2 GMD Report Coverage 9
2.3 Definitions 9
3 Executive Summary 10
3.1 Market Introduction and Overview 10
3.2 Industry Challenges 10
3.3 Market Drivers 10
3.4 Market Restraints 11
3.5 Total Market Revenue Forecasts to 2020 11
3.6 Revenue Share Analysis by Product Types 12
3.7 Competitive Landscape 13
3.8 Conclusion 13
4 North America Active Pharmaceutical Ingredients Market 14
4.1 Market Overview and Introduction 14
4.2 Product Types 14
4.2.1 Types Based on Synthesis Routes 15
4.2.2 Types based on Customer Base 15
4.3 Industry Structure 16
4.4 Industry Challenges 17
4.4.1 Maturity of the Synthetic API Market Hampers the Profit Margin Growth 17
4.4.2 High Cost Restricts the Development of New Drugs in the North American API Market 17
4.4.3 Regulatory Challenges Lead to Delay in Launch of the Drugs in the Market 18
4.4.4 Attempts to Introduce Biogenerics in the Market May Lead to the Loss of Competitive Edge for Many Biotech API Producers 18
4.5 Market Drivers 19
4.5.1 Growth in Pharmaceutical Industry Keeps the API Market Growing in North America 19
4.5.2 Generic Sector Spurs the Growth of the API Market in North America 20
4.5.3 Increasing Focus on Biological Drugs Pulls the Growth of the API Market in North America 20
4.6 Market Restraints 20
4.6.1 Economic Downturn Causes Reduction in the Growth of the API Market 20
4.6.2 Reducing Focus on Innovative sector Hampers the Growth of the North American API Market 20
4.6.3 Patent Expiry of the Blockbuster Molecules Will Restrain the Growth of the API Market in North America 21
4.6.4 Increasing Competition from China and India Creates Pricing Pressure 21
4.7 Total Revenue Forecasts 22
4.8 Analysis by Product Types Based on Synthesis Routes 24
4.8.1 Revenue Share Analysis 24
4.8.2 North America Synthetic API Market Analysis 25
4.8.3 North America Biotech Market Analysis 31
4.8.4 Revenue Share Trend Analysis by Product Types 39
4.9 Analysis of North American Synthetic API Market by Customer Base 40
4.9.1 Revenue Share Analysis 40
4.9.2 North America Innovative Synthetic API Market Analysis 41
4.9.3 North America Generic Synthetic API Market Analysis 47
4.9.4 Revenue Share Trend Analysis by Customer Base 53
4.10 Analysis by Therapeutic Applications 54
4.11 Analysis by Countries 56
4.12 Competitive Structure 59
4.13 Market Trends 59
4.13.1 Increasing Focus on HPAPI 59
4.13.2 Increasing Number of Development Projects in Therapeutic Peptide Area 59
4.14 Market Share Analysis 60
5 United States Active Pharmaceutical Ingredients Market 62
5.1 Market Introduction and Overview 62
5.2 Market Drivers 62
5.2.1 Growth in Pharmaceutical Industry Drives the Overall Growth of the API Market in the United States 62
5.2.2 Generic Drugs Sector Fuels the growth of the API Market in the United States 63
5.3 Market Restraints 64
5.3.1 Downturn in Economy Hampers the Growth of the United States API Market 64
5.3.2 Price Erosion Reduces the Revenue Growth of the United States API Market 64
5.4 Total Revenue Forecasts 65
5.5 Revenue Share Analysis by Product Types 67
5.6 Revenue Forecasts of Synthetic API by Customer Base 69
5.7 Revenue Share Analysis of Synthetic API by Customer Base 71
5.8 Revenue Share Analysis by Therapeutic Applications 72
6 Canada Active Pharmaceutical Ingredients Market 73
6.1 Market Introduction and Overview 73
6.2 Market Drivers 73
6.2.1 Growth in the Pharmaceutical Industry Boosts the Sales of API in Canada 73
6.2.2 Growth in Generics Sector 74
6.3 Market Restraints 75
6.3.1 The Economic Recession Bound to Reduce the Growth of the Canadian API Market 75
6.3.2 Declining Prices Restricts the Growth of the API Market in Canada 75
6.4 Total Revenue Forecasts 76
6.5 Revenue Share Analysis by Product Types 78
6.6 Revenue Forecasts of Synthetic API by Customer Base 79
6.7 Revenue Share Trend Analysis of Synthetic API by Customer Base 81
6.8 Revenue Share Analysis by Therapeutic Applications 82
7 Appendix 83
7.1 Methodology 83
7.1.1 Coverage 83
7.1.2 Secondary Research 84
7.1.3 Primary Research 84
7.1.4 Expert Panel Validation 85
7.2 Unit of Measure 85
7.3 Contact Us 85
7.4 About Global Markets Direct 85
7.5 Disclaimer 85

1.1 List of Tables
Table 1: North America API Market, List of Drugs Going Off-patent in 2009 21
Table 2: North America API Market, Total Revenue Forecasts, 2000-2020 22
Table 3: North America API Market, Revenue Share by Product Types, 2008 24
Table 4: North America Synthetic API Market, Revenue Forecasts, 2000-2020 26
Table 5: North America Synthetic API Market, Revenue Share Analysis by Countries, 2008 27
Table 6: North America Biotech API Market, Revenue Forecasts, 2000-2020 34
Table 7: North America Biotech API Market, Revenue Share Analysis by Countries, 2008 35
Table 8: North America Synthetic API Market, Revenue Share Analysis by Customer Base, 2008 40
Table 9: North America Innovative Synthetic API Market, Revenue Forecasts, 2000-2020 42
Table 10: North America Innovative Synthetic API, Revenue Share Analysis by Countries, 2008 43
Table 11: North America Generic Synthetic API Market, Revenue Forecasts, 2000-2020 48
Table 12: North America Generic Synthetic API Market, Revenue Share Analysis by Countries, 2008 50
Table 13: North America API Market, Revenue Share Analysis by Therapeutic Class, 2008 54
Table 14: North America API Market, Revenue Share Analysis by Countries, 2008 56
Table 15: North America API Market, Revenue Share Analysis by Companies, 2008 60
Table 16: United States API Market, Total Revenue Forecasts by Product Types, 2000-2020 65
Table 17: United States API Market, Revenue Share Trend Analysis by Product Types, 2000-2020 67
Table 18: United States Synthetic API Market, Revenue Forecasts by Customer Base, 2000-2020 69
Table 19: United States Synthetic API Market, Revenue Share Trend Analysis by Customer Base, 2000-2020 71
Table 20: Canada API Market, Total Revenue Forecasts by Product Types, 2000-2020 76
Table 21: Canada API Market, Revenue Share Trend Analysis by Product Types, 2000-2020 78
Table 22: Canada Synthetic API Market, Revenue Forecasts by Customer Base, 2000-2020 79
Table 23: Canada Synthetic API Market, Revenue Share Trend Analysis by Customer Base, 2000-2020 81

1.2 List of Figures
Figure 1: North America Active Pharmaceutical Ingredients Market, Revenue Forecasts, 2000-2020 11
Figure 2: North America Active Pharmaceutical Ingredients Market, Revenue Share Analysis by Product Types, 2008 12
Figure 3: North America API Market, Product Types 14
Figure 4: North America API Market, Value Chain, 2008 16
Figure 5: North America API Market, Drivers and Restraints, 2009-2020 19
Figure 6: North America API Market, Total Revenue Forecasts, 2000-2020 23
Figure 7: North America API Market, Revenue Share by Product Types, 2008 24
Figure 8: North America Synthetic API Market, Revenue Forecasts, 2000-2020 27
Figure 9: North America Synthetic API Market, Revenue Share Analysis by Countries, 2008 28
Figure 10: North America Synthetic API Market, Comparison of Countries by Revenue Growth Rates, 2008-2020 29
Figure 11: North America Synthetic API Market, Revenue Share Trend Analysis by Countries, 2000-2020 30
Figure 12: North America Active Pharmaceutical Ingredients Market, Number of Drug Developments of Biotechnology Medicines by Product Category, 2008 31
Figure 13: North America Active Pharmaceutical Ingredients Market, Share of Therapeutic Areas in Biotech Drug Developments, 2008 32
Figure 14: North America Biotech API Market, Revenue Forecasts, 2000-2020 35
Figure 15: North America Biotech API Market, Revenue Share Analysis by Countries, 2008 36
Figure 16: North America Biotech API Market, Comparison of Growth Rates by Countries, 2008-2020 37
Figure 17: North America Biotech API Market, Revenue Share Trend Analysis by Countries, 2000-2020 38
Figure 18: North America API Market, Revenue Share Trend Analysis by Product Types, 2000-2020 39
Figure 19: North America Synthetic API Market, Revenue Share Analysis by Customer Base, 2008 40
Figure 20: North America Innovative Synthetic API Market, Revenue Forecasts, 2000-2020 43
Figure 21: North America Innovative Synthetic API, Revenue Share Analysis by Countries, 2008 44
Figure 22: North America Innovative Synthetic API Market, Comparison of Revenue Growth Rates by Countries, 2000-2020 45
Figure 23: North America Innovative Synthetic API, Revenue Share Trend Analysis by Countries, 2000-2020 46
Figure 24: North America Generic Synthetic API Market, Revenue Forecasts, 2000-2020 49
Figure 25: North America Generic Synthetic API Market, Revenue Share Analysis by Countries, 2008 50
Figure 26: North America Generic Synthetic API Market, Growth Rate Comparison by Countries, 2008-2020 51
Figure 27: North America Generic Synthetic API Market, Revenue Share Trend Analysis by Countries, 2008-2020 52
Figure 28: North America Synthetic API Market, Revenue Share Trend Analysis by Customer Base, 2000-2020 53
Figure 29: North America API Market, Revenue Share Analysis by Therapeutic Class, 2008 55
Figure 30: North America API Market, Revenue Share Analysis by Countries, 2008 56
Figure 31: North American API Market, Comparison of Growth Rates by Countries, 2008-2020 57
Figure 32: North America API Market, Revenue Share Trend Analysis by Countries, 2000-2020 58
Figure 33: North America API Market, Revenue Share Analysis by Companies, 2008 60
Figure 34: United States API Market, Growth of Pharmaceutical Industry, 2004-2008 62
Figure 35: Untied States API Market, Projections of Aging Population (>85 yrs), 2000-2050 63
Figure 36: United States API Market, Total Revenue Forecasts by Product Types, 2000-2020 66
Figure 37: United States API Market, Revenue Share Trend Analysis by Product Types, 2000-2020 68
Figure 38: United States Synthetic API Market, Revenue Forecasts by Customer Base, 2000-2020 70
Figure 39: United States Synthetic API Market, Revenue Share Trend Analysis by Customer Base, 2000-2020 71
Figure 40: United States API Market, Revenue Share Analysis by Therapeutic Applications, 2008 72
Figure 41: Canada API Market, Pharmaceutical Spending Growth, 2000-2008 74
Figure 42: Canada API Market, Total Revenue Forecasts by Product Types, 2000-2020 77
Figure 43: Canada API Market, Revenue Share Trend Analysis by Product Types, 2000-2020 78
Figure 44: Canada Synthetic API Market, Revenue Forecasts by Customer Base, 2000-2020 80
Figure 45: Canada Synthetic API Market, Revenue Share Trend Analysis by Customer Base, 2000-2020 81
Figure 46: Canada API Market, Revenue Share Analysis by Therapeutic Applications, 2008 82
Figure 47: Methodology 83

Change Currency

GBP

EURO

USD

Last Viewed

North America Active Pharmaceutical Ingredients Market Analysis and Forecasts to 2020

Thoresen Thai Agencies Public Company Limited (TTA) - Financial and Strategic Analysis Review

Expeditors International of Washington, Inc. (EXPD) - Financial and Strategic Analysis Review

What is Working in IVD: Successful Commercialization of New Products and Technologies

Merrill Lynch, Pierce, Fenner & Smith Incorporated - Clean Technology - Advisory Profile

Chemicals Company Profiles

Find Chemicals Company Profiles, with SWOT analysis and latest financials.

Become an Affiliate

Do you manage an industry specific website or blog? Are you looking to monetise your web traffic further? Are you a B2B website?

Why not offer your visitors industry specific strategic market reports and company profiles? Our Affiliate Program enables you to provide quality content on your website and to earn money from passing on visitors to our website. If a sale is made from your visitor, you earn commission (a fixed percentage of the price of a product).

Custom Research

Cannot find what you need? We can tailor a report for you. Complete the Custom Research Form and we will provide a quote.

Chemicals	Type	Keywords Phrase All Words Any Word
Microsoft Windows users can hold the CTRL Key to select more than one sector or country at a time. Apple users can hold the CMD Key to do the same.	Country	Industry Sector
Publisher	Order By Relevance Date	Published In

North America Active Pharmaceutical Ingredients Market Analysis and Forecasts to 2020

Select License Type

In-depth analysis of the North American active pharmaceutical ingredients (API) market

Speak to an Advisor

Select License Type

Table of Contents

Change Currency

Last Viewed

Chemicals Company Profiles

Become an Affiliate

Custom Research

News

Market Insights

Companies And Markets

Customer Support

Corporate Accounts

Contact Details

Contrast settings

Text size settings

All
Afghanistan
Africa
Albania
Algeria
American Samoa
Andorra
Angola
Anguilla
Antigua and Barbuda
Argentina
Armenia
Aruba
Asia
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia
Bosnia-Herzegovina
Botswana
Bouvet Island
Brazil
British Virgin Islands
Brunei
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Canada
Cape Verde
Caribbean
Cayman Islands
Central African Republic
Central America
Central Europe
Chad
Chile
China
Christmas Island
Cocos (Keeling) Islands
Colombia
Comoros
Conch Republic
Cook Islands
Costa Rica
Croatia
Cuba
Cyprus
Czech Republic
Democratic Republic of Congo
Denmark
Djibouti
Dominica
Dominican Republic
Eastern Europe
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Europe
Falkland Islands
Faroe Islands
Fiji
Finland
France
French Guiana
French Southern Territories
Gabon
Gambia
Georgia
Germany
Ghana
Gibraltar
Global
Greece
Greenland
Grenada
Guadeloupe (French)
Guam (USA)
Guatemala
Guernsey
Guinea
Guinea Bissau
Guyana
Haiti
Heard Island and McDonald Islans
Holy See
Honduras
Hong Kong
Hungary
Iceland
India
Indonesia
Iran
Iraq
Ireland
Israel
Italy
Ivory Coast
Ivory Coast (Cote D`Ivoire)
Jamaica
Japan
Jersey
Jordan
Kazakhstan
Kenya
Kiribati
Kurdistan
Kuwait
Kyrgyzstan
Laos
Latvia
Lebanon
Lesotho
Liberia
Libya
Liechtenstein
Lithuania
Luxembourg
Macau
Macedonia
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Martinique (French)
Mauritania
Mauritius
Mayotte
Mexico
Micronesia
Middle East
Moldova
Monaco
Mongolia
Montenegro
Montserrat
Morocco
Mozambique
Myanmar
Namibia
Nauru
Nepal
Netherlands
Netherlands Antilles
New Caledonia (French)
New Zealand
Nicaragua
Niger
Nigeria
Niue
Norfolk Island
North America
North Korea
Northern Mariana Islands
Norway
Oman
Pakistan
Palau
Palestinian Territory
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Pitcairn Island
Poland
Polynesia (French)
Portugal
Puerto Rico
Qatar
Reunion
Romania
Russia
Rwanda
Saint Barthelemy
Saint Helena
Saint Kitts and Nevis
Saint Lucia
Saint Martin
Saint Pierre and Miquelon
Saint Vincent and Grenadines
Samoa
San Marino
Sao Tome and Principe
Saudi Arabia
Scandinavia
Schengen countries
Senegal
Serbia and Montenegro
Seychelles
Sierra Leone
Singapore
Slovakia
Slovenia
Solomon Islands
Somalia
South Africa
South America
South Georgia and the South Sandwich Islands
South Korea
Spain
Sri Lanka
Sudan
Suriname
Svalbard and Jan Mayen Islands
Swaziland
Sweden
Switzerland
Syria
Taiwan
Tajikistan
Tanzania
Thailand
Timor-Leste (East Timor)
Togo
Tokelau
Tonga
Trinidad and Tobago
Tunisia
Turkey
Turkmenistan
Turks and Caicos Islands
Tuvalu
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States
United States Minor Outlying Islands
Uruguay
Uzbekistan
Vanuatu
Venezuela
Vietnam
Virgin Islands
Wallis and Futuna Islands
Western Sahara
Yemen
Zambia
Zimbabwe

All
Aerospace
Agriculture, Farming & Raw Materials
Automotive and Parts
Business Services
Chemicals
Construction
Consumer Goods
Defence
Energy and Utilities
Environmental
Finance and Banking
Food and Drink
Healthcare and Medical
Industrial
Information Technology
Leisure
Logistics
Media
Paper and Packaging
Publishing and Printing
Real Estate
Retail
Security
Telecommunications
Textiles and Clothing
Transportation
Travel